Viewing Study NCT00915694


Ignite Creation Date: 2025-12-25 @ 1:31 AM
Ignite Modification Date: 2026-02-24 @ 3:16 PM
Study NCT ID: NCT00915694
Status: TERMINATED
Last Update Posted: 2019-04-23
First Post: 2009-06-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme
Sponsor: Abramson Cancer Center at Penn Medicine
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain and Central Nervous System Tumors View
Keywords:

Keywords

Keyword Brief Keyword Text View
None adult giant cell glioblastoma View
None adult gliosarcoma View
None adult glioblastoma View